C4 Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
C4 Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes C4 Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes WATERTOWN, Mass., Dec. 17, 2020 — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroys disease-causing proteins through degradation, today announced that the Company will be added to the Russell 2000 ® and Russell 3000 The Russell 2000 ® Index measu...
Source: globalbankingandfinance.com